Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

In recent years, breakthroughs have been made in tumor immunotherapy. However, tumor immunotherapy, particularly anti-PD-1/PD-L1 immune checkpoint inhibitors, is effective in only a small percentage of patients in solid cancer. How to improve the efficiency of cancer immunotherapy is an urgent probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Liping, Liu, Yang, Liu, Lin, Gao, Shuochen, Gao, Xueyan, Feng, Yudi, Sun, Zhenqiang, Zhang, Yan, Wang, Chengzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912573/
https://www.ncbi.nlm.nih.gov/pubmed/36759842
http://dx.doi.org/10.1186/s12943-023-01731-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912573/
https://www.ncbi.nlm.nih.gov/pubmed/36759842
http://dx.doi.org/10.1186/s12943-023-01731-z

Ejemplares similares